Physician profile
Anthony Maffei
NPI 1104093236
$17,295.81
in general payments reported to CMS, 2019-2025
15 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $181 · 2020: $57.12 · 2021: $240 · 2022: $2,147 · 2023: $14K · 2024: $433 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,785 · Food and Beverage: $3,085 · Travel and Lodging: $2,786 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,784.66 |
| Food and Beverage | $3,084.53 |
| Travel and Lodging | $2,786.25 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,843.83 | 2021-2024 | Davinci Xi, Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $961.11 | 2023-2025 | Seamguard, Gore Enform Preperitoneal Biomaterial, Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Medtronic, INC. | $811.07 | 2022-2025 | Endo Gia Ultra, Signia, Ligasure |
| Stryker Corporation | $583.94 | 2022 | |
| Davol INC. | $323.30 | 2019-2024 | Phasix Mesh |
| Novo Nordisk INC | $231.49 | 2022-2024 | Wegovy, Saxenda, Rybelsus |
| Dilon Technologies, INC. | $146.60 | 2024 | Hemoblast Bellows |
| Abbvie INC. | $120.80 | 2024 | |
| Currax Pharmaceuticals LLC | $110.13 | 2020-2024 | Contrave, Onzetra Xsail |
| Heron Therapeutics, INC. | $40.99 | 2022-2023 | Aponvie |
| Ethicon US, LLC | $37.07 | 2019 | |
| Covidien LP | $29.07 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.53 | 2022 | |
| Lilly USA, LLC | $19.10 | 2025 | Zepbound |
| Nalpropion Pharmaceuticals LLC | $13.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Maffei listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.